Proteomic analysis of blood samples from pregnant individuals did not improve risk prediction of hypertensive disorders of pregnancy compared to current methods, underscoring the demand for more accurate prediction tools, according to findings published in JAMA Cardiology.
Browsing: Preventive Medicine
Circulating protein levels may serve as a biomarker for cardiorespiratory fitness, an important but previously hard-to-measure component of overall health, according to a study published in Nature Medicine.
Postmenopausal women who took calcium and vitamin D supplements demonstrated reduced cancer mortality but increased cardiovascular mortality after a 20-year follow-up period, according to post-hoc analysis results published in Annals of Internal Medicine.
A large international team led by a Northwestern Medicine investigator has established new standardized diagnostic criteria for pediatric sepsis, according to two related studies published in JAMA.
Mercedes Carnethon, PhD, vice chair and Mary Harris Thompson Professor of Preventive Medicine and co-chair of the Appointments, Promotions, and Tenure Committee at Northwestern University Feinberg School of Medicine, has been named chair of the Department of Preventive Medicine, effective September 1.
Investigators have identified more than 60 previously unknown genetic variants associated with resting heart rate that may also contribute to increased risk of cardiovascular disease, according to findings published in Nature Communications.
The Coronary Artery Risk Development in Young Adults (CARDIA) study has received a 10-year $11 million grant renewal from the National Heart, Lung, and Blood Institute at the National Institutes of Health.
Time-restricted eating without calorie counting was as effective as a calorie restriction diet for weight loss and cardiometabolic risk reduction in obese adults, according to findings published in Annals of Internal Medicine.
Metformin, a drug commonly used to treat diabetes, may prevent the development of “long COVID,” according to a clinical trial published in The Lancet Infectious Diseases.
People genetically predisposed to have high LDL cholesterol are at an increased risk for coronary heart disease even if their cholesterol levels are only modestly elevated, according to a recent study published in Circulation.